RxDoctor Payments Data

Collin Fuller, MD

Dermatology · Philadelphia, PANPI 1891157129

Payments from drug & device makers

$1,810in general payments, 2019–2025

Across 73 payments — averaging $24.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$778
  • Johnson & Johnson$369
  • Novartis$236
  • Helsinn Therapeutics (U.S.), Inc.$118
  • Lilly USA, LLC$82
  • Sanofi$63
  • plus $163 from 5 others

What the payments were for

  • Food & beverage$1,71595%
  • Education$955%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,810 in reported general payments places this provider in the 50th percentile of 626 dermatology providers in Pennsylvania.

See all dermatology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$1,023,189
Medicare patients
6,142
Services billed
14,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab12$77,663
Humira PenAdalimumab11$74,017
Dupixent PenDupilumab14$52,366
Clobetasol Propionate258$24,051
Ketoconazole428$6,404
Fluocinonide85$3,618
Metronidazole51$3,153
Triamcinolone Acetonide216$3,019
Clindamycin Phosphate45$2,167
Mometasone Furoate67$2,043
Hydrocortisone113$1,211
Tretinoin14$1,070
Fluorouracil14$953
Hydroxychloroquine Sulfate14$523
Mupirocin39$372

Paid to pharmacies, not to this prescriber.

Other dermatology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →